Which has grown faster, ARWR or HSIC?

Over the past five years, ARWR grew revenue faster — ARWR at a 44.14% CAGR versus HSIC at 2.71%.

Is ARWR or HSIC more profitable?

HSIC runs the higher net margin — ARWR at -47.79% versus HSIC at 2.96%.

How have ARWR and HSIC total returns compared?

Over the past 10 years, ARWR delivered 23.56% and HSIC delivered 2.90% annualized total return. Past performance doesn't predict future results.

Arrowhead Pharmaceuticals, Inc. (ARWR) vs Henry Schein, Inc. (HSIC)

A side-by-side comparison of Arrowhead Pharmaceuticals, Inc. and Henry Schein, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ARWR

Arrowhead Pharmaceuticals, Inc.

$8.78B

$62.35HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

HSIC

Henry Schein, Inc.

$9.60B

$84.23HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

Total return — ARWR vs HSIC

growth of $100 · dividends reinvested · last 10y

ARWR +755.3% (+23.9%/yr)HSIC +31.7% (+2.8%/yr)ARWR compounded faster over this window

Log scale — wide-divergence pair

ARWR HSIC

ARWR vs HSIC: by the numbers

•HSIC is the larger company ($9.60B vs $8.78B market cap).
•HSIC is profitable (2.96% net margin) while ARWR runs a net loss (-47.79%).
•ARWR grew revenue faster over the past five years (44.14% vs 2.71% CAGR).

Metrics side by side

Valuation

Metric	ARWR	HSIC
P/E ratio	N/A	24.56
Forward P/E	N/A	15.64
PEG ratio	N/A	7.77
P/S ratio	13.12	0.71
P/B ratio	18.87	3.04
EV / EBITDA	N/A	12.19
FCF yield	N/A	5.62%

Profitability

Metric	ARWR	HSIC
Gross margin	100.00%	30.31%
Operating margin	11.86%	5.69%
Net margin	-47.79%	2.96%
ROE	-68.73%	12.77%
ROIC	-12.12%	6.53%

Growth (annualized)

Metric	ARWR	HSIC
Revenue CAGR (5Y)	44.14%	2.71%
EPS CAGR (5Y)	N/A	3.14%
FCF CAGR (5Y)	N/A	0.82%
Total return CAGR (5Y)	0.75%	1.39%

Frequently asked

Which has grown faster, ARWR or HSIC?: Over the past five years, ARWR grew revenue faster — ARWR at a 44.14% CAGR versus HSIC at 2.71%.
Is ARWR or HSIC more profitable?: HSIC runs the higher net margin — ARWR at -47.79% versus HSIC at 2.96%.
How have ARWR and HSIC total returns compared?: Over the past 10 years, ARWR delivered 23.56% and HSIC delivered 2.90% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ARWR analysis Full HSIC analysis Interactive comparison tool

Dig into the metrics

Henry Schein P/E ratio Arrowhead Pharmaceuticals ROE Henry Schein ROE Arrowhead Pharmaceuticals operating margin Henry Schein operating margin Arrowhead Pharmaceuticals revenue growth Henry Schein revenue growth Arrowhead Pharmaceuticals free cash flow Henry Schein free cash flow

Arrowhead Pharmaceuticals & Henry Schein appear in these rankings

Fastest Revenue Growth Stocks Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.